HLA-DR4 antigen and idiopathic dilated cardiomyopathy susceptibility: A meta-analysis involving 11,761 subjects

Tissue Antigens

Volumn 77, Issue 2, 2011, Pages 107-111

  Jin, B ^a   Ni, H ^a   Geshang, Q ^a   Li, Y ^a   Shen, W ^a   Shi, H ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dilated cardiomyopathy; Human leukocyte antigen DR; Meta analysis; Polymorphism

Indexed keywords

HLA DR4 ANTIGEN;

ALLELE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISEASE PREDISPOSITION; ETHNICITY; EUROPE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART MUSCLE BIOPSY; HLA SYSTEM; HUMAN; PENETRANCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HLA-DR4 ANTIGEN; HUMANS; RISK FACTORS;

EID: 78650926331     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01589.x     Document Type: Article

References (29)

1. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994: 331: 1564-75.
2. Bender JR. Idiopathic dilated cardiomyopathy. An immunologic, genetic, or infectious disease, or all of the above? Circulation 1991: 83: 704-6.
3. Agarwal AK, White AG, Ali M, Leheny WA, Daar AS. HLA antigens in an Omani population with dilated cardiomyopathy. Int J Cardiol 1996: 55: 29-32.
4. Anderson JL, Carlquist JF, Lutz JR, DeWitt CW, Hammond EH. HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am J Cardiol 1984: 53: 1326-30.
5. Arbustini E, Gavazzi A, Pozzi R et al. The morphologic spectrum of dilated cardiomyopathy and its relation to immune-response genes. Am J Cardiol 1989: 64: 991-5.
6. Caforio AL, Martinetti M, Schwarz G et al. Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992: 39: 236-40.
7. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. Circulation 1991: 83: 515-22.
8. Carlquist JF, Ward RH, Husebye D, Feolo M, Anderson JL. Major histocompatibility complex class II gene frequencies by serologic and deoxyribonucleic acid genomic typing in idiopathic dilated cardiomyopathy. Am J Cardiol 1994: 74: 918-20.
9. Grant SC, Sheldon S, Dyer PA, Levy RD, Brooks NH. Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy? Br Heart J 1994: 71: 76-8.
10. Harcombe AA, Sharples L, Large SR, Wallwork J, Weissberg PL, Joysey V. HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy. Int J Cardiol 1999: 68: 31-7.
11. Komajda M, Raffoux C, Salame E et al. HLA A-B and DR in dilated myocardiopathies. Arch Mal Coeur Vaiss 1987: 80: 1233-37.
12. Limas CJ, Limas C. HLA antigens in idiopathic dilated cardiomyopathy. Br Heart J 1989: 62: 379-83.
13. Liu W, Li WM, Yang SS et al. Association of HLA class II DRB1, DPA1 and DPB1 polymorphism with genetic susceptibility to idiopathic dilated cardiomyopathy in Chinese Han nationality. Autoimmunity 2006: 39: 461-7.
14. Lozano MD, Rubocki RJ, Wilson JE, McManus BM, Wisecarver JL. Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis treatment trial investigators. J Card Fail 1997: 3: 97-103.
15. Mahjoub S, Mehri S, Ghazouani E et al. HLA class II polymorphisms in Tunisian patients with dilated cardiomyopathy. Tissue Antigens 2010: 75: 679-83.
16. Maharaj B, Hammond MG. HLA-A, B, DR, and DQ antigens in black patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1990: 65: 1402-3.
17. Nishi H, Koga Y, Koyanagi T et al. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy. J Mol Cell Cardiol 1995: 27: 2385-92.
18. Osa A, Almenar L, Palencia M, Puig N, Chirivella M, Montoro J. Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy. Clin Cardiol 1999: 22: 292-6.
19. Rodríguez-Pérez JM, Fragoso JM, Alvarez-León E et al. MHC class II genes in Mexican patients with idiopathic dilated cardiomyopathy. Exp Mol Pathol 2007: 82: 49-52.
20. Wang Q, Liao Y, Gong F, Mao H, Zhang J. HLA-DRB1 gene polymorphism in patients with dilated cardiomyopathy. J Tongji Med Univ 2000: 20: 141-2.
21. Zerbe TR, Kaufmann C, Colson Y, Duquesnoy R. Associations of HLA-A, B, DR antigens with primary disease in cardiac allograft recipients. Am J Cardiol 1988: 61: 1359-61.
22. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980: 44: 672-3.
23. Richardson P, McKenna W, Bristow M et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996: 93: 841-2.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002: 21: 1539-58.
25. Limas CJ, Limas C, Kubo SH, Olivari MT. Anti-beta-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol 1990: 65: 483-7.
26. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002: 4: 411-7.
27. Hirschhorn JN, Lohmueller K, Byrne E. A comprehensive review of genetic association studies. Genet Med 2002: 4: 45-61.
28. Wacholder S, Chanock S, Garcia-Closas M. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004: 96: 434-42.
29. Villar J, Piaggio G. Large trials or meta-analysis? That is not the question. Best Pract Res Clin Obstet Gynaecol 2005: 19: 27-35.